|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Total operating expenses | |||||
| Finance (expenses) income | |||||
| Loss before income tax | |||||
| Income tax expense | |||||
| Net Loss | |||||
| Other comprehensive (loss) / income | |||||
| Items that may be reclassified to profit or loss: | |||||
| Exchange (loss) gain arising on translation of foreign operations | |||||
| Total comprehensive loss attributable to: | |||||
| Equity holders of the Company | |||||
| Basic loss per share | |||||
| Diluted loss per share |
Loading...
